Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS)

ObjectiveTo report the impact of visual field quality control (QC) procedures on the rates of visual field unreliability, test parameter errors, and visual field defects attributed to testing artifacts in the Ocular Hypertension Treatment Study (OHTS). MethodsOHTS technicians were certified for perimetry and were required to submit 2 sets of visual fields that met study criteria before testing study participants. The OHTS Visual Field Reading Center (VFRC) evaluated 46,777 visual fields completed by 1618 OHTS participants between February 1994 and December 2003. Visual field QC errors, rates of unreliability, and defects attributed to testing artifacts were assessed. The OHTS QC system addressed 3 areas of clinic performance: (1) test parameter errors, (2) patient data errors, and (3) shipment errors. A visual field was classified as unreliable if any of the reliability indices exceeded the 33% limit. Clinical sites were immediately contacted by the VFRC via fax, e-mail, and/or phone and instructed on how to prevent further testing errors on fields with defects attributed to testing artifacts. Main Outcome MeasuresQC errors (test parameter errors) and unreliability rates. ResultsA total of 2.4% (1136/ 46,777) of the visual fields were unreliable and 0.23% (107/46,777) had incorrect test parameters. Visual field defects attributed to testing artifacts occurred in approximately 1% (483/46,777) of the visual fields. ConclusionsPrompt transmission of visual fields to the VFRC for ongoing and intensive QC monitoring and rapid feedback to technicians helps to reduce the frequency of unreliable visual fields and incorrect testing parameters. Visual field defects attributed to testing artifacts were infrequent in the OHTS.

[1]  Chris A. Johnson,et al.  Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. , 1995, Archives of ophthalmology.

[2]  Chris A. Johnson,et al.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.

[3]  G. Trick,et al.  Assessing the utility of reliability indices for automated visual fields. Testing ocular hypertensives. , 1989, Ophthalmology.

[4]  Michael Wall,et al.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.

[5]  Chris A. Johnson,et al.  Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial , 1994 .

[6]  C A Johnson,et al.  Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). , 1993, Controlled clinical trials.

[7]  Chris A. Johnson,et al.  CONFIRMATION OF VISUAL FIELD ABNORMALITIES IN THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS) , 1999 .

[8]  M. Wall,et al.  Effect of instructions on conventional automated perimetry. , 2000, Investigative ophthalmology & visual science.

[9]  M. Kass,et al.  The Ocular Hypertension Treatment Study: design and baseline description of the participants. , 1999, Archives of ophthalmology.

[10]  Chris A. Johnson,et al.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002 .

[11]  D. Shin,et al.  Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. , 1997, Ophthalmology.

[12]  E. E. Hartmann,et al.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.

[13]  R. Beck,et al.  Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. , 1993, Archives of ophthalmology.

[14]  Chris A Johnson,et al.  Baseline visual field characteristics in the ocular hypertension treatment study. , 2002, Ophthalmology.

[15]  Chris A Johnson,et al.  Classification of visual field abnormalities in the ocular hypertension treatment study. , 2000, Archives of ophthalmology.

[16]  J L Keltner,et al.  Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. , 2000, Archives of ophthalmology.

[17]  M. Brodsky,et al.  Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2004, American journal of ophthalmology.